Kodiak Sciences Inc. financial data

Symbol
KOD on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
1200 Page Mill Rd, Palo Alto, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
Oligasis, LLC (to 7/28/2009)
Latest financial report
10-Q - Q3 2024 - Nov 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 865 % +39.3%
Debt-to-equity 86.2 % +29.9%
Return On Equity -84.5 % -14.4%
Return On Assets -45.4 % -2.21%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 52.6M shares +0.29%
Common Stock, Shares, Outstanding 52.6M shares +0.3%
Entity Public Float 222M USD -8.33%
Common Stock, Value, Issued 5K USD 0%
Weighted Average Number of Shares Outstanding, Basic 52.6M shares +0.31%
Weighted Average Number of Shares Outstanding, Diluted 52.6M shares +0.31%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 141M USD -34.6%
General and Administrative Expense 63.1M USD -12.8%
Operating Income (Loss) -204M USD +29.2%
Net Income (Loss) Attributable to Parent -192M USD +29.4%
Earnings Per Share, Basic -3.66 USD/shares +29.3%
Earnings Per Share, Diluted -3.66 USD/shares +29.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 198M USD -42.8%
Marketable Securities, Current 0 USD -100%
Assets, Current 202M USD -42.3%
Property, Plant and Equipment, Net 107M USD -14.8%
Operating Lease, Right-of-Use Asset 48.6M USD -14%
Other Assets, Noncurrent 8.74M USD +0.09%
Assets 373M USD -32%
Accounts Payable, Current 3.29M USD -91.5%
Employee-related Liabilities, Current 5.04M USD -6.81%
Accrued Liabilities, Current 10.6M USD -54.4%
Liabilities, Current 24.1M USD -66%
Operating Lease, Liability, Noncurrent 63.2M USD -15.1%
Other Liabilities, Noncurrent 0 USD -100%
Liabilities 187M USD -23.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax 0 USD
Retained Earnings (Accumulated Deficit) -1.28B USD -17.5%
Stockholders' Equity Attributable to Parent 185M USD -38.7%
Liabilities and Equity 373M USD -32%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -39.6M USD +16.1%
Net Cash Provided by (Used in) Financing Activities 38K USD
Net Cash Provided by (Used in) Investing Activities -166K USD -100%
Common Stock, Shares Authorized 490M shares 0%
Common Stock, Shares, Issued 52.6M shares +0.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Deferred Tax Assets, Valuation Allowance 373M USD +7.39%
Deferred Tax Assets, Gross 386M USD +5.03%
Operating Lease, Liability 81.6M USD -6.95%
Depreciation 4.7M USD +23.4%
Payments to Acquire Property, Plant, and Equipment 22K USD -99.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -192M USD +28.7%
Lessee, Operating Lease, Liability, to be Paid 105M USD -10.6%
Property, Plant and Equipment, Gross 143M USD +127%
Operating Lease, Liability, Current 10.2M USD +13.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 16.3M USD +8.64%
Lessee, Operating Lease, Liability, to be Paid, Year One 14.8M USD -5.16%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 23.3M USD -16.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 16.6M USD +7.17%
Deferred Tax Assets, Operating Loss Carryforwards 134M USD +14.2%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 8.25M USD +8.8%
Lessee, Operating Lease, Liability, to be Paid, Year Four 9.84M USD -38.2%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 12.2M USD -37.2%
Share-based Payment Arrangement, Expense 74.4M USD -18.7%
Interest Expense 0 USD -100%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%